Table 5.
Antifungal treatment, length of stay, and outcome in presumed CAPA cases
| Sex/Age | Length of stay | Fungal species | Antifungal treatment | Outcome |
|---|---|---|---|---|
| M/83 | 1 week | Aspergillus fumigatus | Amphotericin B 50 mg/day, Caspofungin | Died |
| M/79 | 5 days | Aspergillus flavus | Amphotericin B 50 mg/day, Posaconazole 300 mg/day, Itraconazole | Died |
| M/64 | 9 days | Aspergillus flavus | Amphotericin B 250 mg/day, Voriconazole 200 mg/day | Survived |
| F/56 | 10 days | Aspergillus fumigatus | Amphotericin B 50 mg/day, Caspofungin | Died |
| M/77 | 12 days | Aspergillus fumigatus | Amphotericin B 50 mg/day, Posaconazole 300 mg/day, Itraconazole | Died |
| M/86 | 2 weeks | Aspergillus fumigatus | Amphotericin B 50 mg/day, Caspofungin | Died |
| M/59 | 2 weeks | Aspergillus flavus | Amphotericin B 300 mg/day, Voriconazole 200 mg/day | Survived |
| M/73 | 9 days | Aspergillus fumigatus | Amphotericin B 50 mg/day, Posaconazole 300 mg/day, Nystatin | Survived |
| M/87 | 2 weeks | Aspergillus oryzae | Amphotericin B 50 mg/day, Caspofungin | Died |
| F/76 | 6 weeks | Aspergillus flavus | Caspofungin, Itraconazole | Died |
| M/78 | 6 days | Aspergillus fumigatus | Amphotericin B 50 mg/day, Caspofungin | Died |
| F/69 | 1 week | Aspergillus oryzae | Voriconazole 200 mg/day, Caspofungin | Died |
| M/78 | 1 week | Aspergillus fumigatus | Voriconazole 200 mg/day, Caspofungin | Died |
| M/88 | 6 days | Aspergillus flavus | Amphotericin B 50 mg/day, Posaconazole 300 mg/day | Survived |
| F/45 | 5 days | Aspergillus fumigatus | Amphotericin B 50 mg/day, Caspofungin | Died |
| F/86 | 1 week | Aspergillus oryzae | Amphotericin B 50 mg/day, Caspofungin | Died |
| M/70 | 5 days | Aspergillus fumigatus | Caspofungin | Died |
F female, M male